OverT Bio forms Clinical Advisory Board to advance OVT-101, a scalable CAR-T therapy targeting CLDN6 for ovarian and other solid tumors.

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Scientists have discovered another mechanism through which cancer cells thrive. (Koto_feja/E+/Getty Images) A group of natural compounds attracting attention for their anti-aging potential has a dark ...

Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

Recent data suggests people taking GLP-1 drugs may develop colorectal cancer less often than those taking aspirin, a ...

The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) ...

Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon ...